Metabolic Disease: When Biology Advances, but Care Lags

Metabolic Disease: When Biology Advances, but Care Lags – RamaOnHealthcare

Metabolic diseases, including type 2 diabetes (T2D), obesity, and metabolic syndrome, are a growing threat to global public health. More than 537 million adults currently live with T2D, and this number continues to rise, especially in developing countries where sedentary lifestyles and poor diets are driving the surge. These conditions impose a substantial economic burden on [...]

Metabolic Disease: When Biology Advances, but Care Lags

Advances such as triple agonists, gene editing, and microbiome therapy offer hope for metabolic diseases, but global access and early detection remain limited.

When Biology Advances, but Care Lags

Metabolic diseases, including type 2 diabetes (T2D), obesity, and metabolic syndrome, are a growing threat to global public health. More than 537 million adults currently live with T2D, and this number continues to rise, especially in developing countries where sedentary lifestyles and poor diets are driving the surge. These conditions impose a substantial economic burden on […] The post When Biology Advances, but Care Lags first appeared on New…